Perifosine in Treating Patients With Advanced Pancreatic Cancer

NCT00053924 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

OTHER

Sponsor class

Conditions

Pancreatic Cancer

Interventions

DRUG: perifosine

Sponsor

University Health Network, Toronto

Collaborators

[object Object]